Abstract

H1 Patent – European patent – Application for revocation; Validity; Polynucleotide sequence encoding a Neutrokine-α polypeptide; Identification by bioinformatics – No supporting data from in vitro or in vivo studies – Whether invention capable of industrial application – Insufficiency – Appeal to Court of Appeal – Trial judge’s decision on invalidity upheld – Invention not susceptible of industrial application – Appeal to Supreme Court – Appeal allowed – Case remitted to Court of Appeal – Insufficiency – Enablement – Whether claims limited to products which were “useful” – Whether relevant that the utility of members of a claimed class of antibodies could not be identified without undue effort – Broadening amendment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.